"Designing Growth Strategies is in our DNA"
Supraglottic airway devices is a set of medical devices that acts as a passageway, by keeping the upper airway open for oxygenation and administration of anesthetic gases and ventilation. Having replaced the traditional endotracheal intubation and face masks, the usage of supraglottic airway devices has increased over the last few decades and has become a fundamental tool in modern anesthesiology.
Supraglottic airway devices were initially used for simple procedures, but then became increasingly implemented in critical scenarios such as emergencies and in situations, where intubation is difficult. Benefits of supraglottic airway devices include higher speed & ease of insertion, lower autonomic impact, and less post-operative discomfort for the patients.
They also have advantages from the perspective of health economics by reducing the additional use of anesthetics, anti-emetics, and patient complications. The World Federation of Societies of Anesthesiologists (WFSA) estimates that every year, around 230 million major surgeries are carried worldwide, thus necessitating proper anesthesia procedures. The Supraglottic airway devices market is expected to undergo considerable growth during the forecast period due to the increasing prevalence of acute and chronic diseases, which often require anesthesia.
To gain extensive insights into the market, Request for Customization
During surgical procedures, anesthesia has become a crucial factor as it reduces the level of pain. Due to the increasing prevalence of acute and chronic diseases such as cancers and other traumatic injuries like traumas, accidents, etc., one of the first lines of treatment is the surgical procedures, for which the patient undergoes anesthesia. This is responsible for driving the supraglottic airway devices market growth during the forecast period.
However, the adverse or negative effects associated with the supraglottic airway devices are the market restraining factors. Some of the complications include aspiration, airway traumas, compression of surrounding lingual, and mental nerves, which can lead to life-threatening conditions for the patients.
Some of the major companies that are present in the supraglottic airway devices market are Medtronic, Teleflex Incorporated, Smiths Medical, Ambu A/S, Karl Storz Se & Co. KG, Flexicare Medical Limited, Verathon Inc., Intersurgical Ltd, Mercury Medical, and other players.
SEGMENTATION | DETAILS |
By Product Type | · Laryngeal Mask Airways (LMA) · Oropharyngeal Airways (OPA) · Nasopharyngeal Airways (NPA) · Others |
By Age Group | · Adults · Neonates/Pediatrics |
By End-User | · Hospitals · Ambulatory Surgery Centers · Others |
By Geography | · North America (the USA, and Canada) · Europe (UK, Germany, France, Italy, Spain, Scandinavia, and Rest of Europe) · Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific) · Latin America (Brazil, Mexico, and Rest of Latin America) · Middle East & Africa (South Africa, GCC, and Rest of the Middle East & Africa) |
In 2018, laryngeal mask airways (LMA) accounted for the largest proportion in the supraglottic airway devices market owing to its advantages over other product types which includes less post-operation discomfort, swiftness, safety in insertion, and lower autonomic impact. The segment is projected to continue its dominance in terms of market share during the forecast period.
The supraglottic airway devices market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is dominating the supraglottic airway devices market share owing to its ongoing R&D initiatives by public and private players, increasing adoption of technologically advanced devices, and increasing rate of surgical procedures. The Asia Pacific is expected to register significant growth during the forecast period attributing to the rising adoption of anesthesia devices, increasing rates of accidents, injuries, surgeries, etc., and expansion of medical devices industries.
US +1 833 909 2966 ( Toll Free )